Study: New Mapping Method Improves Detection of Leukemia Abnormalities
Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.
Read MorePosted by CLP Edit Staff | Jun 4, 2026 | Cancer, Leukemia, Molecular Diagnostics |
Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.
Read MorePosted by CLP Edit Staff | Apr 21, 2026 | Leukemia, Molecular Diagnostics |
Optical genome mapping detected clinically significant genetic variants missed by standard tests in nearly 20% of acute leukemia cases, according to a 200-patient study.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Transfusion & Transplantation Tests |
Modern diagnostic tools are enabling higher-resolution HLA typing for stem cell transplants, supporting faster and more precise donor-recipient matching.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Molecular Diagnostics, Womens Health |
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Leukemia |
Caris Life Sciences has launched Caris ChromoSeq, a whole genome and transcriptome sequencing assay for myeloid malignancies, designed to consolidate multiple tests into a single workflow with a seven-day turnaround.
Read More